#ECTRIMS2018

Best tweets:

Susanna van Tonder 16/12/2018 12:07
Sometimes lesions are not visible on MRIs MRI can potentially miss up to 40% of lesions. So we need to mindful of this before declaring a possible #relapse a #pseudo-exacerbation https:// youtu.be/smTgGeWhfEM   #ectrims2018 #wehavems #multiplesclerosis #complex
81.8% Patients on GA Depot Demonstrated No Evidence of Disease Activity (NEDA) at 2 years GA Depot Has Potential to Address Multiple Sclerosis Treatment Burden and Improve Patient Compliance NESS ZION...
National MS Society 16/10/2018 05:57
"People with MS have been asking for years about diet–is there a diet that works for MS? Does what you eat matter?" Learn about the latest findings in diet and #MS presented at last week's ECTRIMS, the world’s largest #MSresearch conference. #ECTRIMS2018: https:// ntlms.org/DietMatters  
http://pic.twitter.com/YQ4kBb0sDV
"People with MS have been asking for years about diet–is there a diet that works for MS? Does what you eat matter?"  Learn about the latest findings in diet and #MS presented at last week's ECTRIMS, the world’s largest #MSresearch conference. #ECTRIMS2018:  https:// ntlms.org/DietMatters      <br>http://pic.twitter.com/YQ4kBb0sDV
The data presented at ECTRIMS 2018 build on the existing real-world and clinical evidence around the safety and efficacy of cladribine tablets and reaffirm the benefit-risk profile of the oral treatme...
National MS Society 15/10/2018 02:43
Innovative research is being done in the area of brain repair mechanisms in MS. Read some of the latest findings presented at the #ECTRIMS2018, the world’s largest #MSresearch conference: https:// ntlms.org/EmergingTherap iesBlog   …
http://pic.twitter.com/6ioVSpEtZs
Innovative research is being done in the area of brain repair mechanisms in MS. Read some of the latest findings presented at the #ECTRIMS2018, the world’s largest #MSresearch conference:  https:// ntlms.org/EmergingTherap iesBlog   …  <br>http://pic.twitter.com/6ioVSpEtZs
Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced that results from the phase III study of satralizumab (development code: SA237), SAkuraSky Study (NCT02028884), were presented at the Congress of ...
QueenSquareMSCentre 15/10/2018 06:39
Prof Jeremy Chataway discussing results of the MS-SMART study with @medwireNews at #ECTRIMS2018 @UCLIoN @UCLBrainScience @UCLHresearch https:// twitter.com/medwireNews/st atus/1051569918490107905   …
Follow Roche on Twitter via @Roche and keep up to date with ECTRIMS 2018 news and updates by using the hashtag #ECTRIMS2018. OCREVUS is a humanised monoclonal antibody designed to selectively target C...
Kate Petheram 13/10/2018 06:44
The course of MS is not easy to predict. Aggressive disease can hit late. Should avoid labelling all worsening as ‘progression’ and remain proactive in individual patients #ECTRIMS2018
http://pic.twitter.com/2ZVHOKRTdH
The course of MS is not easy to predict. Aggressive disease can hit late. Should avoid labelling all worsening as ‘progression’ and remain proactive in individual patients #ECTRIMS2018 <br>http://pic.twitter.com/2ZVHOKRTdH
Ozanimod showed effects on cognitive processing speed in a post hoc analysis of 12-month data from SUNBEAM™ pivotal trial In separate post hoc analysis of pooled data from phase 3 RADIANCE™ Part B and ...
Nat Rev Neurology 12/10/2018 07:25
Finally, a little late-breaking news of our own - a new Timeline by @MarTintore and colleagues, charting the development of multiple sclerosis therapies over the past 25 years, has just gone online: https:// go.nature.com/2EhklOT   #newfromnrneurology #ECTRIMS2018
http://pic.twitter.com/wu95B49yh7
Finally, a little late-breaking news of our own - a new Timeline by @MarTintore and colleagues, charting the development of multiple sclerosis therapies over the past 25 years, has just gone online:  https:// go.nature.com/2EhklOT      #newfromnrneurology #ECTRIMS2018 <br>http://pic.twitter.com/wu95B49yh7
QueenSquareMSCentre 12/10/2018 04:09
Two studies from Queen Square #MS Centre featured in the #ECTRIMS2018 clinical highlights session
http://pic.twitter.com/Ngb4acvUv7
Two studies from Queen Square #MS Centre featured in the #ECTRIMS2018 clinical highlights session <br>http://pic.twitter.com/Ngb4acvUv7
ECTRIMS Congress 12/10/2018 04:02
The World's largest meeting in #MS has come to an end. We would like to thank all participants, faculty members and helpers who have contributed to a marvellous #ECTRIMS2018. Take care and safe travels home. #ECTRIMS
http://pic.twitter.com/h4ri3CdzC2
The World's largest meeting in #MS has come to an end. We would like to thank all participants, faculty members and helpers who have contributed to a marvellous #ECTRIMS2018.  Take care and safe travels home. #ECTRIMS<br>http://pic.twitter.com/h4ri3CdzC2
ECTRIMS Congress 12/10/2018 03:38
Congratulations to #ECTRIMS2018 Poster PrizeWinners: R. Ouelette S. Collorone T. Maragkou K.A. Meijer J. Lohrscheider
http://pic.twitter.com/oKmyQ4liGC
Congratulations to #ECTRIMS2018 Poster PrizeWinners: R. Ouelette S. Collorone T. Maragkou K.A. Meijer J. Lohrscheider <br>http://pic.twitter.com/oKmyQ4liGC
Cambridge Neuroimmunology 12/10/2018 01:31
Congratulations to Jeremy Chataway and the MS SMART team for delivering a clear result from testing three drugs in progressive MS, using an innovative trial design. Sorry the result was negative. #ECTRIMS2018
topsy
Mar Tintore 12/10/2018 01:02
Phase II study of #Evobrutinib in active relapsing #MS met primary endpoint. Excellent Late Breaking News Platform presentation by @XMontalban #ECTRIMS2018 @cemcat_em
http://pic.twitter.com/wYiljE4uSG
Phase II study of #Evobrutinib in active relapsing #MS met primary endpoint. Excellent Late Breaking News Platform presentation by @XMontalban #ECTRIMS2018 @cemcat_em<br>http://pic.twitter.com/wYiljE4uSG
Jaume Sastre-Garriga 12/10/2018 01:01
Prof @XMontalban @cemcat_em @vallhebron @StMikesHospital @UofT presents the positive final results of phase II trial on #evobrutinib (significant dose-dependent effect on T1 gadolinium-enhancing lesions) at the late breaking news session #ECTRIMS2018
http://pic.twitter.com/0PWtIO8Man
Prof @XMontalban @cemcat_em @vallhebron @StMikesHospital @UofT presents the positive final results of phase II trial on #evobrutinib (significant dose-dependent effect on T1 gadolinium-enhancing lesions) at the late breaking news session #ECTRIMS2018 <br>http://pic.twitter.com/0PWtIO8Man
Genentech 12/10/2018 01:00
Interested in how we're exploring the use of smartphone tech to potentially gain a better understanding of #MS disease activity & disability progression? Find out more about our FLOODLIGHT Open trial below. #ECTRIMS2018
David Martin 12/10/2018 12:46
Smoking makes brain fog worse for MSers over first years after diagnosis according to new study announced at #ECTRIMS2018 Just stop!
Oona Häikiö 12/10/2018 12:11
"There is no benign form of MS!" Great three days in #Berlin #ECTRIMS2018 #multiplesclerosis #MS
http://pic.twitter.com/NtHD4MJALH
"There is no benign form of MS!" Great three days in #Berlin #ECTRIMS2018  #multiplesclerosis #MS<br>http://pic.twitter.com/NtHD4MJALH
Stefania De Trane 12/10/2018 10:50
#BartsMS at #ECTRIMS2018 T25FW and 9-HPT & the importance of #selfmonitoring in MS #thinkhand
http://pic.twitter.com/EEjsdEZlKR
#BartsMS at #ECTRIMS2018 T25FW and 9-HPT  & the importance of #selfmonitoring in MS  #thinkhand<br>http://pic.twitter.com/EEjsdEZlKR
Lluís Ramió-Torrentà 12/10/2018 09:23
@XMontalban @StMichaelHospit @cemcat_em: excelent review of Progresive MS and clinical trials for its treatment. Which subgroup of PwPMS should be treated? Some clues have been shown but further research needs to be done #ECTRIMS2018
http://pic.twitter.com/I6KGmN1BO7
@XMontalban @StMichaelHospit @cemcat_em: excelent review of Progresive MS and clinical trials for its treatment. Which subgroup of PwPMS should be treated? Some clues have been shown but further research needs to be done #ECTRIMS2018 <br>http://pic.twitter.com/I6KGmN1BO7
Sarah-Jane Martin 12/10/2018 06:30
Come and check out our poster- it’s a nice calming shade of blue. #neurofilament #ECTRIMS2018
http://pic.twitter.com/hpdIFAKk74
Come and check out our poster- it’s a nice calming shade of blue. #neurofilament #ECTRIMS2018 <br>http://pic.twitter.com/hpdIFAKk74
Sue Pavitt 11/10/2018 03:49
#Ectrims2018 #shared decision making Helen Ford brilliant engaging talk on patient focused delivery of treatment decisions towards MS shared decision making see Ana Manzano’s poster. “We’ll test your blood for an infection that might kill you”
http://pic.twitter.com/Z5ukp00Fnk
#Ectrims2018 #shared decision making Helen Ford brilliant engaging talk on patient focused delivery of treatment decisions towards MS shared decision making see Ana Manzano’s poster. “We’ll test your blood for an infection that might kill you”<br>http://pic.twitter.com/Z5ukp00Fnk
Overcoming MS 11/10/2018 10:31
Prof @GavinGiovannoni making some very powerful statements in support of early action by clinicians to avoid unnecessary time wasted. Brain Health time matters #MS #MultipleSclerosis #MSTimeMatters #ECTRIMS2018
http://pic.twitter.com/ZHDrYtS02n
Prof @GavinGiovannoni making some very powerful statements in support of early action by clinicians to avoid unnecessary time wasted. Brain Health time matters #MS #MultipleSclerosis #MSTimeMatters #ECTRIMS2018 <br>http://pic.twitter.com/ZHDrYtS02n
Read More on Twitter